Search for: "Ely v. State"
Results 341 - 360
of 1,089
Sort by Relevance
|
Sort by Date
16 Oct 2017, 2:57 am
” In its recent judgment of 2 October 2017 (Eli Lilly v. [read post]
6 Oct 2017, 2:34 pm
Eli Lilly, the court reaffirmed that written description is determined based on the state of the art as of a patent’s priority date and that evidence which illuminates the state of the art only subsequent to the priority date is not relevant to written description. [read post]
6 Oct 2017, 2:34 pm
Eli Lilly, the court reaffirmed that written description is determined based on the state of the art as of a patent’s priority date and that evidence which illuminates the state of the art only subsequent to the priority date is not relevant to written description. [read post]
4 Oct 2017, 6:00 am
Nathan Yaffe, Transnational Arbitral Res JudicataSilke Noa Kumpf, Equity-Based Discretion and the Anatomy of Damages Assessment in Investment Treaty LawBoris Kasolowsky, Eric Leikin, Eli Lilly v. [read post]
25 Sep 2017, 7:22 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
25 Sep 2017, 7:22 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
23 Sep 2017, 12:39 pm
Cir. 2015); Eli Lilly, 845 F.3d at 1370. [read post]
19 Sep 2017, 10:13 am
Dankovich v. [read post]
1 Sep 2017, 7:23 am
Oil States v. [read post]
29 Aug 2017, 8:37 am
Quoting Alexander v. [read post]
29 Aug 2017, 8:37 am
Quoting Alexander v. [read post]
18 Aug 2017, 5:56 am
Making sense of trade mark conflict in the EUTM systemKatfriend Darren Meale reports on the CJEU decision Continental Reifen Deutschland v Compagnie generale des etablissements Michelinwhich upheld tyre giant Continental’s appeal against Michelin, concerning their stylised registered mark ‘X’.The challenge of protecting a database without a sui generis right, this time from SingaporeKat friends Lau Kok Keng, Nicholas Lauw and Jiamin Leow report on… [read post]
10 Aug 2017, 3:41 pm
| "Big Box" not found generic or lacking distinctive character, but still .... | Changes to the Singapore copyright system: an update on the recent public consultations | he diplomatic crisis of Qatar and Gulf Cooperation Council's IP | Bundesgerichtshof's landmark ruling to hook extra-territorial patent infringement in Germany | BREAKING: Eli Lilly success as UK Supreme Court finds Actavis products directly and indirectly infringe pemetrexed patent | Monday Miscellany |… [read post]
25 Jul 2017, 5:34 am
UNCT/14/2 Eli Lilly & Co. v Government of Canada, (16 March 2017) ICSID At 10:00 on 17 Aug 2017 I shall give a talk to the IP Summer School at Cambridge entitled Bilateral Investment Treaties & Exporters' Rights Post-Brexit. [read post]
17 Jul 2017, 3:39 pm
Here as promised is the second part of this GuestKat's commentary on Eli Lilly v Actavis UK [2017] UKSC 48, which promises to have much ink spilled and air of various temperatures emitted on its behalf in the coming weeks, months and years. [read post]
15 Jul 2017, 5:11 am
The summary stated that the Supreme Court allows Eli Lilly's appeal and holds that Actavis' products directly infringe Eli Lilly's patent in the United Kingdom, France, Italy and Spain. [read post]
14 Jul 2017, 2:38 pm
Ely,68 N.Y.2d 520, 527 [1986]; People v. [read post]
13 Jul 2017, 8:47 am
Thirteen years after the House of Lords had firmly shut the door on any notion of a doctrine extending the scope of patent protection outside the claims, the UK Supreme Court in yesterday’s judgment in Actavis v Eli Lilly [2017] UKSC 48 reversed gear and reintroduced a true form of doctrine of equivalents into UK law. [read post]
13 Jul 2017, 8:47 am
Thirteen years after the House of Lords had firmly shut the door on any notion of a doctrine extending the scope of patent protection outside the claims, the UK Supreme Court in yesterday’s judgment in Actavis v Eli Lilly [2017] UKSC 48 reversed gear and reintroduced a true form of doctrine of equivalents into UK law. [read post]
12 Jul 2017, 1:34 pm
It is here - the Supreme Court's decision in Eli Lilly v Actavis UK [2017] UKSC 48. [read post]
